Unconventional therapies for cancer: 1. Essiac

CMAJ. Canadian Medical Association Journal

Volumn 158, Issue 7, 1998, Pages 897-902

  Kaegi, Elizabeth ^a  

^a Societe canadienne du cancer   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; HYDRAZINE SULFATE; RETINOL;

ALTERNATIVE MEDICINE; BREAST CANCER; CANCER THERAPY; FEMALE; HUMAN; REVIEW; TEA; VISCUM ALBUM;

EID: 0032492669     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Angus Reid Poll: Alternative medicine [press release]. 1997 Sept 1.
2. Berger E, editor. The Canadian Health Monitor. [Surveys conducted from 1990 to 1998]. Toronto: Price Waterhouse.
3. Rhoads PAI, Tong TG, Banner W, Anderson R. Andcholinergic poisonings associated \vith commercial burdock root tea. Clin Toxicol 1985;22(6):581-4.
4. Russfield AB. Pathology report. Project no C-l 14 [Essiac experiments]. Cambridge (AIA): Bio-Research Consultants; 1959.
5. Gray C. Laetrile: Canada's legal position firm but pressure in the South grows. CMAJ 1977;! 17:1068-74. [sidebar, p. 1069]
6. Essiac: an ineffective cancer treatment. Ottawa: Health Protection Branch, Department of National Health and Welfare; 1989.
7. Guyatt B. Cancer. Toronto: University of Toronto Library Archives; 1977.
8. Thomas R. The Essiac report: the true story of a Canadian herbal cancer remedy and of the thousands oflii'fs it continues to sai'e. 3rd ed. Los Angeles: Alternative Treatment Information Network; 1993.
9. Duke JA. CRC handbook of medicinal herbs. 4th éd. Boca Raton (FL): CRC Press; 1987. Introduction, p. 53-4,106-7,200,404,414-6,495-6,517-23.
10. Crellin JK, Philpott J, editors. Herbal medicine past and present: a reference guide to medicinal plants, vol 2. Durham (NC): Duke University Press; 1990.
11. Kato A, Ando K, Tamura G, Arima K. Effects of some fatty acid esters on the viability and transplantability of Ehrlich ascitcs tumor cells. Cancer Res 1971; 31:501-4.
12. Miyamoto K, Nomura M, Sasakura AI, Alatsui E, Koshiura R, Alurayama T, et al. Antitumor activity of oenothein B, a unique macrocyclic ellagitannin. JpnJ Cancer Res 1993;84:99-103.
13. Yanagihara K, Ito A, Toge T, Numoto AI. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 1993;53:5815-21.
14. Wong CK, Leung KN, Fung KP, Choy YA1. Immunomodulatory and antitumour polysaccharidcs from medicinal p\znts.J IntAIed Res 1994;22:299-312.
15. Driscoll JS, Hazard GF, Wood HB, Goldin A. Structure-antitumor relation-ships among quinone derivatives. Cancer CbeîtiotberRep 1974;4(2):l-27.
16. Dombradi CA, Földedk S. Screening report on the antitumor activity of purified Araium laffa extracts. Tumori 1966;52:173-6.
17. Belkin AI, Fitzgerald DB. Tumor-damaging capacity of plant materials: I. Plants used as calfarùcs.JKatl Cancer hist 1952;13:139-55.
18. Ma L. [Experimental study on the immunomodulatory effects of rhubarb] (Chinese). Cbung Hsi I Cbieb Ho Tsa Cbib 1991;! 1(7):390,418-9.
19. ,19. Kupchan S.M, Karim A. Tumor inhibitors: 114. Aloe emodin: antileukemic principle isolated from Rbawmisfrangiila L. Uoydia 1977;39(4):223-4.
20. Alasuda T, Ueno Y. Alicrosomal transformation of emodin into a direct mutagen.A/aw/R 1984;125:135-44.
21. Lee H, Tsai SJ. Effect of emodin on cooked-food mutagen activation. Food Cbem Toximl 1991;29(11):765-70.
22. Monta II, Umeda AI, Alasuda T, Ueno Y. Cytotoxic and mutagenic effects of emodin on cultured mouse carcinoma FAI3A cells. Mutât Res 1988;204:329-32.